User profiles for S. Bota
Sarah E BotaLondon Health Sciences Centre Verified email at lhsc.on.ca Cited by 794 |
Meta‐analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis
S Bota, H Herkner, I Sporea, P Salzl, R Sirli… - Liver …, 2013 - Wiley Online Library
… and depth are also reported, and the results of the elasticity are expressed in m/s 27, 28. …
fibrosis was 1.30 ± 0.07 m/s (median 1.31 m/s) and values ranged between 1.19–1.43 m/s. …
fibrosis was 1.30 ± 0.07 m/s (median 1.31 m/s) and values ranged between 1.19–1.43 m/s. …
2-Amino-1, 3, 4-thiadiazole as a potential scaffold for promising antimicrobial agents
…, O Stanasel, E Serban, S Bota - Drug design, development …, 2018 - Taylor & Francis
… Upadhyay and Mishra Citation62 synthesized the 5-(4-substituted phenyl)-1,3,4-thiadiazol-2-amine
derivatives 8 and performed in vitro antibacterial activity against S. aureus, Bacillus …
derivatives 8 and performed in vitro antibacterial activity against S. aureus, Bacillus …
[HTML][HTML] EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)
…, J Bamber, A Berzigotti, S Bota… - Ultraschall in der …, 2017 - thieme-connect.com
… time determined by the shear wave speed c s . Shear wave speed may be displayed … s may
be converted to either Young’s modulus E or shear modulus G, using the equations E = 3ρc s …
be converted to either Young’s modulus E or shear modulus G, using the equations E = 3ρc s …
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma
S Bota, F Piscaglia, S Marinelli, A Pecorelli, E Terzi… - Liver cancer, 2012 - karger.com
The aim of this review is to present the similarities and differences between the latest guidelines
for noninvasive diagnosis of hepatocelullar carcinoma (HCC) of American Association …
for noninvasive diagnosis of hepatocelullar carcinoma (HCC) of American Association …
Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis
Background & Aims Nonselective β blockers (NSBBs) reduce portal pressure and the risk
for variceal hemorrhage in patients with cirrhosis. However, development of spontaneous …
for variceal hemorrhage in patients with cirrhosis. However, development of spontaneous …
[HTML][HTML] Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a …
…, H Lena, J Hureaux, H Berard, D Paillotin, S Bota… - Annals of oncology, 2011 - Elsevier
Background Brain metastases (BM) occur in up to 40% of non-small-cell lung cancer (NSCLC)
patients. This trial assessed the safety and efficacy of pemetrexed–cisplatin in this …
patients. This trial assessed the safety and efficacy of pemetrexed–cisplatin in this …
[PDF][PDF] Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized …
…, M Marcq, C Decroisette, JB Auliac, S Bota… - J Clin …, 2016 - researchgate.net
… CGA can predict morbidity and mortality in elderly patients with cancer11 and can help to
adapt cancer management to each patient’s fitness or frailty.Balducci and Extermann13 used a …
adapt cancer management to each patient’s fitness or frailty.Balducci and Extermann13 used a …
Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study
I Sporea, S Bota, M Peck-Radosavljevic, R Sirli… - European journal of …, 2012 - Elsevier
… A total of 5 (Saga), 6 (Bologna, Verona) or 10 valid measurements (the other centers included
in this study) were performed in every patient and a median value in m/s was calculated. If …
in this study) were performed in every patient and a median value in m/s was calculated. If …
[HTML][HTML] Crizotinib in c-MET-or ROS1-positive NSCLC: results of the AcSé phase II trial
…, F Barlési, B Mennecier, I Monnet, R Sabatier, S Bota… - Annals of oncology, 2019 - Elsevier
Background In 2013, the French National Cancer Institute initiated the AcSé program to
provide patients with secure access to targeted therapies outside of their marketed approvals. …
provide patients with secure access to targeted therapies outside of their marketed approvals. …
Follow-up of Bronchial Precancerous Lesions and Carcinoma in Situ Using Fluorescence Endoscopy
S Bota, JB Auliac, C Paris, J Métayer… - American journal of …, 2001 - atsjournals.org
… In a recent study, S. Lam and colleagues found the same prevalence of precancerous …
P, Sutedja T, Watson A, Weiss SMolecular Biomarkers Workshop. A European strategy for …
P, Sutedja T, Watson A, Weiss SMolecular Biomarkers Workshop. A European strategy for …